This story is from December 10, 2021

Daily Covid-19 tests surpass 10k mark after a month

Daily Covid-19 tests surpass 10k mark after a month
Nagpur: Daily Covid-19 tests have significantly increased across Vidarbha in the last few days. The average daily test count was under 7,000 for the last four weeks. However, after Omicron fear, many districts have resumed their policy of conducting random tests in the last 10 days.
The number is increasing daily. On Thursday, over 10,000 tests were performed in the last 24 hours for the first time in a month.

The 11 districts of Vidarbha together conducted 10,681 tests and reported 22 positive patients. This means, the test positivity rate is just 0.20%.
The number of new cases was again higher than the number of recoveries. The number of under-treatment patients increased to 174, which is highest since October last week.
The day saw 14 patients recovering in Vidarbha. Recovery rate is consistently above 98%. No death was reported on Thursday.
As far as Nagpur is concerned, the district conducted 4,278 tests in the last 24 hours. Out of 11 new patients, nine are from Nagpur city and two from district.
Of the eights patients who recovered, five are patients from other states, two are from Nagpur rural and only one from city. Now, 86 patients are under treatment in the district. Home isolation of asymptomatic or mild symptomatic patients is still not permitted in Nagpur. All have to go for institutional isolation.

Wardha: One more positive from 512 tests has increased the total count of cases to 49,433, while one more discharged also increased the total recoveries to 48,098, leaving five active positive patients under treatment. The toll remained unchanged at 1,326 as no new death was reported Thursday.
Yavatmal: The district saw no death on Thursday, keeping the toll unchanged at 1,788. Currently there are 24 active positive patients under treatment. The administration received 526 test reports of which one woman from Pusad was found positive. Of the 72,959 positive patients, 71,147 including one on Thursday have recovered. The test positivity rate is 9.48%, death rate is 2.45% and daily positivity rate is 0.19%. There are 1,753 beds available for covid patients in the hospitals across the district.
Amravati: One new case out of 677 samples tested took the district’s caseload to 96,143 on Thursday. As there were no recoveries and no deaths, the number of active cases under treatment went up by one to 11.
Chandrapur: Covid active figures remained stable at 14, following solitary detection and equal number of recoveries on Thursday . There was no casualty reported. The lone patient detected belonged to Chandrapur city. Covid caseload has grown to 88,864 which include 87,307 recoveries and 1,543 deaths. A total of 1,553 tests were conducted during last 24 hours. Total sample tested amounts to 7,74,452, out of which 6,83,685 have recovered.
Akola: 571 tests were conducted and two of them came positive, taking the caseload to 57,906. One patient recovered, taking total recovery count to 56,756. Now, 10 patients are under treatment.
Washim: There was neither a new case nor any recovery on Thursday. Now, out of the 41,778 patients detected so far, 41,134 have recovered while 639 have died. Four patients are under treatment.
Buldhana: Of the 270 tests conducted in the last 24 hours, one returned positive. The caseload reached 87,655, including 86,969 recoveries and 675 deaths so far. Now, 11 patients are under treatment.
Gadchiroli: Four out of 1,345 tests conducted in the last 24 hours came positive, taking the caseload to 30,826. With no recovery reported during the day, the count reached 30,072. The number of under treatment patient has reached seven.
Gondia: No new case was reported from 292 tests in the last 24 hours. One patient recovered, leaving two under treatment. One of them is in home isolation while other is admitted to hospital.
Bhandara: All 431 tests conducted in the last 24 hours returned negative. The district has no patient under treatment for the fifth day in a row.
End of Article
FOLLOW US ON SOCIAL MEDIA